Transforming The Future Of Interventional Cardiology
Through international collaborations
PULSE Issue 43 | July 2024
Wrapping up on a resounding note, the recently concluded EuroPCR congress, held in the traditional venue of Palais des Congrès, Paris, France from 14 to 17 May 2024, saw a record turnout of over 12,000 attendees at the world’s largest interventional cardiology meeting!
A unique opportunity for the exchange of knowledge, skills and experience, the NUHCS team shone on the global stage, led by Prof Tan Huay Cheem, Senior Advisor, NUHCS, and A/Prof Adrian Low, Senior Consultant, Dept. of Cardiology, NUHCS, who participated as invited faculty members. Along with the unveiling of the latest clinical evidence and insights across four days of exceptional learning and networking, Prof Tan and A/Prof Low were actively involved in various roles as chairpersons, panel discussants and facilitators, leading attendees to dive into a wide range of topics in cardiovascular care.
Engaging the international attendees in meaningful discussions, Prof Tan not only facilitated exciting live polling and interactive discussions on innovative techniques in modern interventional cardiology, but also tapped on his own expertise by sharing selective strategies in managing high thrombus1 burden in STEMI2 patients to help optimise cardiovascular outcomes, and dived into treatment approaches for navigating the side branch in non-left main bifurcations3, another challenging topic spotlighted. Weighing in on diverse topics, he steered effective discussions revolving around randomised trials and extended followup in the field.
Taking the lead during two enriching sessions as discussant, Prof Low fostered lively discourse and interactions on the immensely useful technique of intracoronary imaging in routine clinical practice, as well as delved into the pros and cons of imaging and other modalities in optimising PCI4 outcomes. Shining the light on learning points in their noteworthy clinical cases, Dr Sim Hui Wen, Consultant, Dept. of Cardiology, NUHCS, and Dr Andrico Tobing, interventional fellow, NUHCS,
also delivered featured presentations on the management of challenging NSTEMI5 patients, and strategies to tackle Chronic Total Occlusions6 (CTO) in the coronary
arteries respectively, to the rapt attention of participants.
Demonstrating our expertise as a national centre, NUHCS is honoured to have played a part in shaping the meaningful exchange of knowledge, experience, and
practice at this international congress of significance. The team will continue the collaboration at this year’s edition of the 2024 AICT-AsiaPCR congress – the official course of the Asian Pacific Society of Interventional Cardiology (APSIC) in collaboration with the larger PCR family, scheduled to be held from 3 to 5 October – where NUHCS will serve as one of the two live transmission centres showcasing important techniques and practice from the NUHCS’ Catheterisation Lab7 to a global audience!
About EuroPCR
EuroPCR is the world-leading course in Interventional Cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). The annual conference is created by and for the cardiovascular community to share knowledge, experience and practice through a series of case presentations, meetings, workshops and discussions. Encouraging the advancement of cardiovascular medicine, awards are also given out in recognition for innovative research and clinical breakthroughs.
1. Thrombus – A blood clot that forms inside one of your veins or arteries.
2. STEMI – ST-elevation myocardial infarction, a type of heart attack that is more serious and has a greater risk of serious complications and death.
3. Bifurcation lesion – A coronary artery narrowing which involves a side branch.
4. PCI – Percutaneous coronary intervention (PCI), commonly known as “stenting” or “ballooning”.
5. NSTEMI – A partial heart attack that usually happens when the heart’s need for oxygen cannot be met.
6. Chronic Total Occlusions – A complete blockage of a coronary artery for more than three months.
7. Catheterisation Lab – Specialised procedure rooms where doctors perform minimally invasive tests and procedures.
